LORD, ABBETT & CO. LLC - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 106 filers reported holding STOKE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.44 and the average weighting 0.7%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$7,822,000
+81.2%
126,303
-2.0%
0.02%
+50.0%
Q3 2020$4,316,000
+36.5%
128,861
-2.9%
0.01%
+27.3%
Q2 2020$3,163,000
-24.3%
132,728
-27.3%
0.01%
-42.1%
Q1 2020$4,178,000182,4610.02%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 3,355,466$69,401,0004.13%
Cormorant Asset Management, LP 1,788,394$38,433,0002.34%
RA Capital Management 1,119,963$24,068,0001.43%
SPHERA FUNDS MANAGEMENT LTD. 346,380$7,384,0001.14%
Redmile Group, LLC 1,017,478$21,866,0000.73%
GILDER GAGNON HOWE & CO LLC 1,876,191$40,319,0000.46%
Perceptive Advisors 671,978$14,440,0000.39%
Casdin Capital, LLC 130,000$2,793,700,0000.29%
OXFORD ASSET MANAGEMENT LLP 116,196$2,497,0000.06%
Granite Point Capital Management, L.P. 17,000$365,0000.06%
View complete list of STOKE THERAPEUTICS INC shareholders